within subject standard deviation in fully replicate design if carry over effect is present [General Sta­tis­tics]

posted by dshah  – India, 2023-06-14 12:37 (749 d 15:17 ago) – Posting: # 23591
Views: 3,627

Hello Ankit!

As per PSG, the recommendation is parallel study.

[image]

❝ So how to calculate Swr when unequal carryover effect is present in full replicate study design?


Moreover, the study population is patient and you can not stop the treatment. So why fully replicate CO study?

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,682 registered users;
31 visitors (0 registered, 31 guests [including 15 identified bots]).
Forum time: 03:55 CEST (Europe/Vienna)

You can do one of two things; just shut up,
which is something I don’t find easy,
or learn an awful lot very fast,
which is what I tried to do.    Jane Fonda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5